Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,159,212
  • Shares Outstanding, K 32,677
  • Annual Sales, $ 2,236 M
  • Annual Income, $ -9,750 K
  • 60-Month Beta 0.79
  • Price/Sales 1.34
  • Price/Cash Flow 15.02
  • Price/Book 2.63
Trade AMED with:

Options Overview Details

View History
  • Implied Volatility 20.96% ( +0.68%)
  • Historical Volatility 22.99%
  • IV Percentile 85%
  • IV Rank 74.04%
  • IV High 26.73% on 06/03/24
  • IV Low 4.52% on 12/21/23
  • Put/Call Vol Ratio 42.68
  • Today's Volume 830
  • Volume Avg (30-Day) 101
  • Put/Call OI Ratio 4.34
  • Today's Open Interest 15,989
  • Open Int (30-Day) 16,020

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 1.22
  • Number of Estimates 6
  • High Estimate 1.34
  • Low Estimate 1.13
  • Prior Year 1.37
  • Growth Rate Est. (year over year) -10.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
90.38 +7.04%
on 06/06/24
96.75 -0.01%
on 07/02/24
+5.59 (+6.13%)
since 05/31/24
3-Month
89.55 +8.03%
on 05/31/24
97.36 -0.63%
on 05/24/24
+4.28 (+4.63%)
since 04/02/24
52-Week
89.55 +8.03%
on 05/31/24
97.36 -0.63%
on 05/24/24
+5.30 (+5.80%)
since 06/30/23

Most Recent Stories

More News
Chewy, Blackrock fall; Spirit AeroSystems, Amedisys rise, Monday, 7/1/2024

Stocks that traded heavily or had substantial price changes on Monday: Chewy, Blackrock fall; Spirit AeroSystems, Amedisys rise

KKR : 105.93 (+1.36%)
EQT : 36.96 (+0.74%)
FANG : 204.90 (+0.58%)
CEG : 206.15 (+0.54%)
BLK : 789.13 (+0.88%)
SPR : 33.88 (-0.26%)
CHWY : 24.87 (-2.24%)
AMED : 96.74 (+0.06%)
Amedisys: Q1 Earnings Snapshot

Amedisys: Q1 Earnings Snapshot

AMED : 96.74 (+0.06%)
Amedisys: Q4 Earnings Snapshot

Amedisys: Q4 Earnings Snapshot

AMED : 96.74 (+0.06%)
Amedisys: Q3 Earnings Snapshot

Amedisys: Q3 Earnings Snapshot

AMED : 96.74 (+0.06%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRTN, AMED, PRTK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TRTN : 79.55 (-4.10%)
AMED : 96.74 (+0.06%)
PRTK : 2.23 (+1.83%)
Amedisys: Q2 Earnings Snapshot

Amedisys: Q2 Earnings Snapshot

AMED : 96.74 (+0.06%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BANC, PACW, AMED

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

BANC : 13.19 (+2.81%)
PACW : 7.54 (-2.71%)
AMED : 96.74 (+0.06%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCF, HCCI, AMED

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CCF : 127.49 (+0.04%)
HCCI : 45.51 (+0.09%)
AMED : 96.74 (+0.06%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGTX, AMED, FRG, DHC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SGTX : 22.47 (-2.56%)
AMED : 96.74 (+0.06%)
FRG : 29.88 (+0.10%)
DHC : 3.18 (+5.65%)
Is UnitedHealth Group Stock a Buy Now?

The nation's largest health insurer has seen its shares fall despite a strong start to the year.

GS : 465.61 (+0.42%)
HUM : 374.82 (+0.36%)
AMED : 96.74 (+0.06%)
LHCG : 169.81 (+0.47%)
UNH : 498.24 (+0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure,...

See More

Key Turning Points

3rd Resistance Point 97.92
2nd Resistance Point 97.33
1st Resistance Point 97.04
Last Price 96.74
1st Support Level 96.15
2nd Support Level 95.56
3rd Support Level 95.27

See More

52-Week High 97.36
Last Price 96.74
Fibonacci 61.8% 94.37
Fibonacci 50% 93.45
Fibonacci 38.2% 92.53
52-Week Low 89.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar